JENNIFER HENNICK: Open Payments
NPI 1083929541 · TIPTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,591 in 94 payments from 38 companies in 2025. Trend: 2023 $1,407 · 2024 $1,485 · 2025 $2,591
Food & beverage: $2,397Education: $194
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $299 |
| Janssen Biotech, Inc. | 8 | $236 |
| Lilly USA, LLC | 5 | $191 |
| Merck Sharp & Dohme LLC | 6 | $184 |
| Kite Pharma, Inc. | 2 | $147 |
| ABBVIE INC. | 6 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| GENZYME CORPORATION | 3 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $88 |
Products named: KEYTRUDA, ERLEADA, EPKINLY, KISQALI, LIBTAYO, RYBREVANT, Fabhalta, VERZENIO.
Industry payments across CA — which companies pay providers there.
